Adaptimmune Therapeutics PLC (ADAP)
1.225
+0.04
(+2.94%)
USD |
NASDAQ |
May 03, 14:17
Adaptimmune Therapeutics 1 Year Total Returns (Daily): -13.14% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | -13.14% |
| May 01, 2024 | -15.38% |
| April 30, 2024 | -16.20% |
| April 29, 2024 | -19.01% |
| April 26, 2024 | -20.96% |
| April 25, 2024 | -19.70% |
| April 24, 2024 | -21.74% |
| April 23, 2024 | -15.56% |
| April 22, 2024 | -25.19% |
| April 19, 2024 | -35.32% |
| April 18, 2024 | -33.45% |
| April 17, 2024 | -28.99% |
| April 16, 2024 | -24.26% |
| April 15, 2024 | -22.79% |
| April 12, 2024 | -2.52% |
| April 11, 2024 | 6.61% |
| April 10, 2024 | 12.39% |
| April 09, 2024 | 26.85% |
| April 08, 2024 | 25.93% |
| April 05, 2024 | 30.48% |
| April 04, 2024 | 31.07% |
| April 03, 2024 | 30.19% |
| April 02, 2024 | 28.44% |
| April 01, 2024 | 34.86% |
| March 28, 2024 | 49.06% |
| Date | Value |
|---|---|
| March 27, 2024 | 43.64% |
| March 26, 2024 | 38.18% |
| March 25, 2024 | 30.91% |
| March 22, 2024 | 29.73% |
| March 21, 2024 | 12.60% |
| March 20, 2024 | 22.02% |
| March 19, 2024 | 25.89% |
| March 18, 2024 | 31.25% |
| March 15, 2024 | 30.97% |
| March 14, 2024 | 26.96% |
| March 13, 2024 | 43.24% |
| March 12, 2024 | 33.04% |
| March 11, 2024 | 37.50% |
| March 08, 2024 | 45.83% |
| March 07, 2024 | 39.20% |
| March 06, 2024 | 29.55% |
| March 05, 2024 | -17.05% |
| March 04, 2024 | -15.91% |
| March 01, 2024 | -3.64% |
| February 29, 2024 | -11.30% |
| February 28, 2024 | -9.04% |
| February 27, 2024 | -6.04% |
| February 26, 2024 | -3.53% |
| February 23, 2024 | -8.64% |
| February 22, 2024 | -14.81% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.35%
Minimum
Oct 08 2019
767.9%
Maximum
Oct 13 2020
8.81%
Average
-44.44%
Median
Nov 17 2022
1 Year Total Returns (Daily) Benchmarks
| Biodexa Pharmaceuticals Plc | -92.30% |
| NuCana PLC | -79.67% |
| Autolus Therapeutics PLC | 109.7% |
| Mereo BioPharma Group PLC | 159.2% |
| TC BioPharm (Holdings) PLC | -93.16% |